Sara Solovitch
Science Journalist and Author
Science journalist and author who has covered psilocybin therapy and the broader psychedelic renaissance for major publications, making clinical research accessible to general audiences.
Biography
Sara Solovitch is a science journalist and author who has covered the psychedelic therapy renaissance for major publications including Wired, the Washington Post, and Scientific American. Her journalism on psilocybin-assisted therapy, the clinical trial landscape, and the personal experiences of patients and therapists has helped translate technically complex research for a broad general readership.
Solovitch's work occupies an important translational role in the psychedelic medicine movement: clinical trial results and neuroscientific findings remain largely inaccessible to the public without skilled science communication. Her reporting has humanized the research by centering patient narratives alongside the data, demonstrating the real-world stakes of the clinical progress being made.
As a journalist operating independently of any single institution or advocacy organization, Solovitch's coverage brings a degree of critical distance to a field where the line between advocacy and research is sometimes blurred. Her book coverage and long-form reporting provide durable reference points for understanding the field's development.
Why They Matter to the LearnShrooms Community
Science journalism translates clinical research into public understanding, which drives the policy changes and public acceptance that determine whether psychedelic therapies reach patients. Solovitch's sustained coverage has helped build informed public discourse around psilocybin therapy at a critical moment in the field's development.
